Wikidata

(Q66405350)

English

A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

clinical trial

In more languages

Statements

title
A Randomized Phase II Clinical Trial Assessing the Efficacy and Safety of MK-3475 (Pembrolizumab) in Combination With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer (English)
0 references
start time
31 May 2016
0 references
end time
October 2019
0 references
number of participants
87
0 references
research intervention
carboplatin
0 references
pembrolizumab
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66405350&oldid=1858902399"